Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Tikosyn (dofetilide) Capsules, Pfizer NDA 20-931 10/4/99 10/4/99 8/16/01 4/4/02 Tikosyn Indication: (1) Maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial blutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm. (2)For the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm. | Tikosyn (dofetilide) Capsules, Pfizer Inc., Labeling Revision | Tikosyn (dofetilide) Capsules, Pfizer Global Research & Development, Approval View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com